 NEW YORK, Aug. 05, 2021 GLOBE NEWSWIRE -- Delcath Systems, Inc. Nasdaq: DCTH, an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today it will participate in two upcoming conferences: 